This study evaluated the morbidity, mortality, and intermediate term follow-up of patients undergoing replacement of their aortoiliac-femoral systems with lower extremity deep and superficial veins.
Results
The in-hospital mortality and amputation rates were 10% each. The mean (± standard deviation [SD] ) operative time was 6.5 ± 1.8 hours and the blood transfusion requirement was 4 ± 3 units. Four patients experienced postoperative gastrointestinal complications with peritonitis and sepsis; NAIS vein graft resisted infection and remained intact. The mean follow-up time was 22.5 ± 16 months. NAISs constructed from GSVs were prone to the development of focal stenoses requiring intervention or diffuse neointimal hyperplasia leading to occlusion. In contrast, all NAISs from larger caliber DVs have remained widely patent. The failure rate of GSV NAISs was 64%, compared to 0% for DV NAISs (p = 0.006). Despite the high failure rate in patients with GSV NAISs, none has required amputation. In patients who had DVs harvested for NAIS reconstruction, limb edema and other signs of venous hypertension have been minimal.
Conclusion
NAIS reconstruction from lower extremity veins is a successful option in patients with extensive aortic prosthetic infection and other complex aortic problems.
Cure of extensive aortic prosthetic infection requires removal of infected prosthetic material and restoration of arterial flow adequate to maintain lower extremity viability. Although multiple operative strategies are available to achieve these objectives, ectopic prosthetic bypass through uninfected tissues coupled with excision of the aortic prosthesis is currently the most widely favored. [1] [2] [3] In recently reported large series, operative mortality rates range from 7% to 25% and amputation rates range from 5% to 25%. [1] [2] [3] [4] [5] This represents a substantial improvement over earlier reports where pooled data from the literature indicated mortality rates of 20% to 48% and amputation rates of 11% to 23%.68 Despite the apparent success of ectopic bypass and excision of infected prosthetic material, major problems remain. Most disappointing is the high rate of acute thrombosis of ectopic prosthetic bypasses. QuinonesBaldrich et al. recently reported a primary patency rate of 43% at 3 years, with a limb loss rate of 33%.9 This is a particularly severe problem in patients with infected aortobifemoral bypasses (AFBs) and extensive vascular occlusive disease who require axillo-unilateral profunda or popliteal bypasses. In addition to a high rate ofthrombosis, reinfection of ectopic prosthetic bypasses and aortic stump blowout remain unresolved issues. Although these problems occur much less frequently than thrombosis, stump blowout is almost always fatal and reinfection of ectopic prostheses often causes limb loss or death.9-l" Dissatisfaction with ectopic prosthetic bypass has led us to rely increasingly upon autogenous, in situ reconstruction after removal of the infected prosthesis. The autogenous approach was originally championed by Ehrenfeld et al. who reported reconstructing the aortoiliac system by disobliterating occluded aortoiliac segments, coupled with arterial and venous autografts. '2 Our approach differs in that we have fashioned a neoaortoiliac system (NAIS) exclusively from superficial and deep lower extremity veins. This report details our experience in patients with extensive aortic prosthetic infections and other complex aortic problems over the past 5 years.
MATERIALS AND METHODS
Since 1988, 21 NAIS procedures have been performed in 20 patients at our institution. A single patient under-went two NAIS procedures-greater saphenous vein (GSV) replacement of right AFB limb followed by replacement of the remainder of the AFB with contralateral deep veins (DVs) 4 years later when left limb infection became manifest. This experience represents 64% of the cases of infected AFBs and aortoenteric erosions (AEEs) or aortoenteric fistulas (AEFs) managed at our institution during this time period. Patients not managed with the NAIS procedure included those presenting with life-threatening AEFs and ruptured anastomotic aneurysms who required emergency operations (n = 4) and those with localized AFB limb infections who were successfully managed with local procedures, which included continuous irrigation with antibiotic solutions, multiple debridements, and muscle flap coverage (n = 6). Only four patients had their original aortic procedure performed at our institution. All patients having NAIS reconstructions have been observed at 6- To harvest a DV autograft, an incision is made over the lateral border of the sartorius muscle beginning in the upper thigh (below the infected groin wound, if present) and extending to the knee (Fig. 1) . The sartorius is reflected medially and the superficial femoral-popliteal vein is isolated. Care is taken to preserve the saphenous nerve, major collateral branches of the superficial femoral and popliteal arteries, and the ipsilateral GSV. The adductor canal is opened by dividing the tendon of the adductor magnus muscle, and multiple branches of the superficial femoral-popliteal vein are carefully ligated and divided; large branches are doubly ligated or suture ligated. An important point is to preserve the profunda femoris vein and leave the common femoral vein intact. The junction of the profunda femoris and the common Figure 1 . Harvest The infected aortic prosthesis is excised and the aorta and periaortic tissues are liberally debrided to achieve a clean proximal anastomotic site and bed for the venous autograft. Suprarenal aortic control by either intraluminal balloon or crossclamp may be necessary to adequately debride the proximal aortic anastomotic site. Three types of proximal anastomoses have been used (Fig. 2) . The DV autograft is simply sutured end-to-end to the aorta ( Fig. 2A) . The largest end of the DV autograft is usually the proximal one and this is most often anastomosed to the aorta. The proximal ends of two GSVs may be sewn together in a "pantaloon" configuration and then anastomosed end-to-end to the aorta (Fig.  2B) . Alternatively, the aortic stump may be oversewn and the venous autografts sutured end-to-side to the anterior aorta (Fig. 2C ). This latter anastomosis has usually been employed when the aorta is too large or the conjoined GSV autograft is too small to perform an end-toend anastomosis. A standard, continuous polypropylene (4-0) suture technique is employed between four quadrant fixation sutures. Care is taken to make more advancement on the aorta than the venous autograft because of the greater circumference of the aorta. Because there is usually a good size match between the DV autograft and the aorta, undue advancement and other techniques to compensate for size discrepancy are usually unnecessary to achieve a "comfortable" anastomosis (Fig. 3) . The infected femoral wounds are then opened and all prosthetic material is removed from below. Debridement ofinfected femoral arterial and surrounding tissues is performed and the tunnels are irrigated with antibacterial solution and mechanically debrided by pulling opened gauze sponges through them. Venous autografts are brought through the old tunnels and anastomosed to the femoral vessels. In many cases, a DV autograft is sutured to the proximal aorta and to the left femoral artery, and a left-to-right DV or GSV iliofemoral (intraabdominal using old right-tunnel) or femoral-femoral bypass is constructed (Fig. 4) . The subcutaneum of the femoral wounds is closed over the venous autografts and the skin is left open. It has not been necessary to cover the venous autografts with muscle flaps. Drainage is rarely employed and antibiotics are usually discontinued in 5 to 7 days. Intermittent pneumatic compression is routinely used postoperatively in patients in whom DV autografts are harvested.
RESULTS
The mean (± SD) age of the 20 patients undergoing NAIS reconstruction was 62 ± 10 years (range, 39 to 77 ((L Among the 17 patients with prosthetic infection, 15 had paninfected AFBs (n = 14) or aortoiliac prostheses (n = 1) with pus surrounding the body and limbs of the prosthesis, and 2 had single AFB limb involvement. All aortic prostheses were knitted Dacron and the indications for original operation were aortoiliac occlusive disease (n = 12), aortic aneurysm combined with occlusive Figure 4 . Aorta to left femoral and femoral-femoral bypass constructed disease (n = 4), and aortic aneurysm (n = 1). The mean from DV autografts harvested from both lower extremities. tion with antibiotic solution coupled with multiple debridement (n = 4), muscle flap coverage (n = 2), and debridement with in situ AFB limb replacement with expanded polytetrafluoroethylene (ePTFE) (n = 2). In addition, one patient had infection ofa secondary AFB 1 year after removal ofan infected primary AFB and placement of axillobifemoral bypass that failed because of multiple, recurrent thromboses. All of these patients were treated with prolonged oral or parenteral antibiotics and had healing before signs of recurrent, more extensive infections developed.
Organisms cultured from excised prosthetic material or pus surrounding prostheses included Staphylococcus epidermidis (n = 7), S. aureus (n = 4; 2 methicillin resistant), Pseudomonas aeruginosa (n = 2), # hemolytic Streptococcus (n = 1), Enterobacter aerogenes (n = 1), Bacteroides bivius (n = 1), Proteus mirabilis (n = 1), Propionibacterium acnes (n = 1), and Candida albicans (n = 1). Four patients had polymicrobial infections and four had no growth with routine culture techniques.
NAIS configurations and the use of GSV and DV autografts are illustrated in Figure 5 . Veins harvested included bilateral GSVs (seven patients), bilateral DVs (three patients), GSVs and DVs from opposite limbs (three patients), and single limb DVs (seven patients). Distal anastomoses were performed to the following outflow arteries: bilateral common femoral (n = 6), bilateral profunda femoris (n = 5), common femoral and opposite profunda femoris or superficial femoral (n = 3), bilateral common iliacs (n = 2), unilateral profunda femoris (n = 2), profunda femoris and opposite superficial femoral (n = 1), and the proximal end of a saphenous vein femoral-distal bypass (n = 1). Suprarenal aortic control was required in four patients. The mean operative time was 6.5 ± 1.8 hours (range, 4.5 to 10 hours) and the intraoperative blood transfusion requirement was 4 ± 3 units (range, 0 to 9 units), with the additional fluid (Ringer's lactate and colloid) requirement being 7 ± 2 L. When two teams were used, operative time was always less than 5 hours.
There were no immediate operative deaths; however, two patients died at 28 days and 35 days after operation (in-hospital mortality rate of 10%) of sepsis and multisystem organ dysfunction after gastrointestinal complications (perforated duodenal diverticulum and ischemic small bowel necrosis). Two others survived acute and gangrenous cholecystitis. These patients are of interest because they had NAISs fashioned from DV autografts and all had generalized peritonitis documented by reoperation with cultures in separate patients yielding E. aerogenes, P. maltophilia, and C. albicans. The patient with the perforated duodenal diverticulum also had pancreatic necrosis and required Roux-en-Y jejunal limb closure of the duodenal defect and three subsequent re-ex- plorations for peritoneal cavity debridement and jejunal anastomotic breakdown. The DV autografts were inspected at all re-explorations for peritonitis; in all four patients, NAIS vein grafts and anastomoses resisted infection and remained intact.
Two patients required above-knee amputation (major amputation rate of 10%). One had pre-existing, nonreversible ischemia from a thrombosed, infected axillo-unilateral femoral bypass. There were no other amputations. Another patient had postoperative DV thrombosis in the lower extremity from which the DV autograft was harvested, and she suffered a nonfatal pulmonary embolus. With the exception ofthis patient, none ofthe limbs from patients in whom the DVs were removed had acute edema.
The mean follow-up time was 22.5 ± 16 months (range, 3 to 60 months). In addition to the two in-hospital deaths, another patient suffered a fatal myocardial infarction and stroke 6 months after NAIS reconstruction. In the remaining 17 patients, important differences in patency were noted between GSV and DV NAIS reconstruction. Three patients with GSV NAISs had total occlusion within 1 year from progressive, diffuse, luminal narrowing documented by duplex ultrasound and angiography (Fig. 6A ). Biopsy at re-exploration confirmed generalized intimal hyperplasia. One of these patients underwent prosthetic replacement AFB; the remaining two have noncritical lower extremity ischemia with severe claudication, but desire no further intervention. Another four patients had focal stenoses in GSV autografts (Fig. 6B) and three required reoperation with patch angioplasty or femoral crossover limb replacement. Again, these occurred within 1 year and were apparent by new onset symptoms, change in examination, or duplex surveillance. Focal stenoses were most commonly found at valve sites (Fig. 6B) or at areas of kinking, especially in small GSV autografts (Fig. 7A) . The proximal anastomotic site was particularly vulnerable to kinks developing in conjoined GSV autografts (Fig. 7B ). Both patients with end-to-side GSV grafts to anterior aortic wall anastomosis (Fig. 2B) experienced total occlusion. Only patients with large GSV autografts (diameter of at least 8 mm) had sustained patency.
In contrast, all NAISs from larger caliber DV autografts have remained patent and nonstenotic. Aneurysmal deterioration also has not occurred. The overall failure rate (occlusion or stenosis requiring reintervention) of GSV NAISs was 64%, compared to 0% for DV NAISs (p = 0.006). Follow-up ankle-brachial indices also reflect the proneness of GSV NAISs to fail. In patient limbs reconstructed with DV NAISs, the preoperative and postoperative ankle brachial indices (ABIs) were 0.65 ± 0.33 and 0.85 + 0.20, respectively (p = 0.07); among patients with GSV NAISs, these values were 0.78 ± 0.24 and 0.45 ± 0.24, respectively (p < 0.001). Despite the failure of GSV NAISs, no amputations were required. Of the 13 patients who had unilateral or bilateral DV harvest, only 2 have had significant chronic limb edema and required compression stockings. One was the patient who had ipsilateral venous thrombosis and the other had the ipsilateral GSVs used for a distal bypass.
DISCUSSION
The surgical challenge imposed by aortic prosthetic infection is reflected in the high mortality and morbidity from operations dealing with this problem. Contemporary results of various approaches are shown in Gram- negative infection is associated with elaboration ofbacterial protease exoproducts that can disrupt vessel walls, especially thin-walled veins. Despite this concern, we have not observed this complication in patients with extensive gram-negative prosthetic infections nor in those who suffered postoperative gastrointestinal problems complicated by widespread peritonitis in whom NAIS vein grafts were virtually bathed in polymicrobial pus.
Our biggest disappointment with the NAIS procedure was the high rate offailure ofGSV autografts. The proneness ofGSV autografts in this position to develop diffuse intimal hyperplasia was also noted by Seeger et al."9 This problem appears limited to small vein grafts, especially when anastomosed to the aorta in the configuration shown in Figure 2C , and in focal areas of kinks or valve sites. For this reason, it is important to monitor these vein grafts with frequent duplex ultrasound examinations and clinical assessment, especially in the first year after placement. Focal stenoses can be corrected by timely reoperation. Despite this limitation, GSV NAIS occlusion is more gradual than the sudden thrombotic occlusion experienced by patients with ectopic prosthetic bypasses who, in our experience, frequently present with profound, irreversible limb ischemia. We, and others, have noted a high rate ofamputation after thrombotic occlusion of axillofemoral bypasses.4'9"' l The slowly progressive occlusion in our patients allowed for early detection, intervention, and, possibly, development of collateral circulation. Notably, none of the occlusions has led to amputations.
In contrast to the experience with GSV NAISs, DV NAISs have remained widely patent. We currently favor DV autografts for NAIS reconstruction and use GSV grafts only if they are large (2 8 mm in diameter). We have not observed focal or diffuse intimal hyperplasia in DV or large GSV autografts. The superficial femoralpopliteal vein has a diameter of 1.0 to 1.5 cm and this allows end-to-end anastomosis to a normal caliber aorta with relative ease. Conjoined GSV grafts at the proximal anastomosis are prone to kinks and other unfavorable hemodynamic conditions that predispose to failure. Another advantage of the DV autograft is that minor kinks and areas of intimal hyperplasia at valve sites do not produce hemodynamic disturbances and compromise flow to the degree that similar sized defects would produce in smaller caliber vein grafts. In the experience of Schulman et al. using DV autografts for femoral-popliteal bypass, very large (> 1.2 cm) diameter DV grafts were prone to failure because of mural thromboembolism. 33 We have not observed this and predict that it will not be a problem because of the better size match be-tween the aortoiliac femoral system and DV autografts. Aneurysmal change also has not been observed, but patients will continue to be monitored for this complication.
The absence of significant limb edema in the majority of patients in whom DV autografts were harvested has been gratifying. This has been the experience of others who have used the DV autograft for femoral-popliteal and other peripheral grafts. Schanzer Second, I must express some concern about the possibility of future dilatation of these large vein grafts. Your observation period is still less than 2 years without aneurysmal dilatation, but I assume that you plan to follow the patients with ultrasound or computed tomography scan to assess graft size and patency at 5 years.
DR. RONALD J. STONEY (San Francisco, California): President MacLean, Fellows and Guests, I enjoyed this paper and had a chance to review Dr. Clagett's manuscript. I think they're to be congratulated for bringing this type of material to the Association since aortoiliac perigrafts infection is a major challenge today among reoperative aortic surgical problems.
The in situ autogenous reconstruction of the aortoiliac system after graft removal, as they report, is simply one option for revascularizing the lower extremities after removal of an infected graft. They prefer the use of the deep veins, and their presentation emphasizes that this provided excellent results in the short term.
Saphenous veins, as one might expect, would predictively be less durable. And this has certainly been true with saphenous veins in other high flow vascular beds as contrasted with the lower extremities where they seem to perform better.
I thought I'd ask one question, and that was relative to the long-term patency that the authors really have not had a chance to experience with their patients. What about the late behavior of these grafts? Like Dr. Smith, I wonder about late aneurysmal or degeneration with stenosis are possible with these deep veins in this position.
These demanding operations were performed in remarkable time with moderate blood requirements and achieved to my knowledge the best record for morbidity and mortality for this problem. Our own experience at the University of California San Francisco was generated with a similar series of patients and was completed long before this series was begun; in fact, our mortality rates were three times what you heard today and amputation rates twice that. These rates were satisfactory at the time, but certainly with better management of patients and better perioperative care, these results have improved.
We are anxious to minimize some of the operative demands on the patients and surgeons for these synchronous operations such as you heard today. We generally favor staged operations removing the graft after actual creation of an alternate or ectopic bypass.
Ifthe authors can show that this technique they report today consistently achieves the same results long term, then I think this would certainly be a major option for management of patients with aortic graft infection. This report could really cause us to reverse our surgical strategies and return to a syndrious rather than a staged approach. As the saying goes, what goes around comes around.
I enjoyed this paper and thank you for the opportunity to discuss it.
DR. GEORGE JOHNSON, JR. (Chapel Hill, North Carolina): Dr. MacLean, Dr. Sheldon, this is another very valuable adjunct for these patients who really have a very serious problem. I think there are several important observations that come from this report. One is that he has removed a tremendous amount of the venous drainage from the lower extremity and reports very minimal edema.
Three questions occurred to me as he presented the paper. First, did he leave the groin wounds open? Stoney has put veins into infected areas, but I believe covered them with muscle. Second, how long did he keep these patients on antibiotics? I notice that he did have some recurrent or perhaps persistent infections at 2 months.
The last and most fascinating question, for which there is perhaps no answer, was about his 20% major gastrointestinal complication rate. Can he explain why 20% of the people had major gastrointestinal complications? This is certainly more than with other abdominal operations. Thank you.
DR. G. PATRICK CLAGETT (Closing discussion): I'd like to thank the discussants for their comments and questions.
Dr. Smith raises appropriate concerns about placing these vein grafts in areas infected by Pseudomonas organisms. Admittedly, our experience is limited in that only three patients has Pseudomonas cultured. Two had preoperative Pseudomonas infections that involved AFB limbs and one had postoperative peritonitis with a Pseudomonas organism. The problem with these organisms is that they elaborate exoproteases that can dissolve vein grafts. We have seen this in some of our trauma patients where vein grafts have been exposed in addition to being infected with Pseudomonas. It is possible that the deep, retroperitoneal position of the NAIS vein grafts affords protection by surrounding the vein grafts with well vascular-
